tiprankstipranks
Trending News
More News >
Axas Holdings Co., Ltd. (JP:3536)
:3536
Japanese Market
Advertisement

Axas Holdings Co., Ltd. (3536) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Axas Holdings Co., Ltd.

(3536)

Rating:60Neutral
Price Target:
¥131.00
▼(-4.38%Downside)
Axas Holdings Co., Ltd. faces challenges in profitability and high leverage, which weigh on its financial performance. The technical indicators point to a positive trend and potential for growth, yet valuation concerns persist due to a negative P/E ratio. The dividend yield offers limited relief. Overall, the stock presents moderate risk with potential for improvement if profitability and leverage issues are addressed.

Axas Holdings Co., Ltd. (3536) vs. iShares MSCI Japan ETF (EWJ)

Axas Holdings Co., Ltd. Business Overview & Revenue Model

Company DescriptionAxas Holdings Co., Ltd. (3536) is a Japanese company primarily engaged in the retail and wholesale of a wide range of general merchandise. The company operates through various segments, including the distribution of household goods, personal care products, and food items. Axas Holdings is known for its diverse product offerings, catering to both individual consumers and businesses across Japan.
How the Company Makes MoneyAxas Holdings Co., Ltd. generates revenue through multiple streams. The primary source of income is the sale of household goods and personal care products through its retail operations. The company operates a network of stores across Japan, where it sells products directly to consumers. Additionally, Axas Holdings engages in wholesale operations, supplying goods to other retailers and businesses. This diversification allows the company to capture a wide customer base and increase its market reach. The company may also form strategic partnerships or alliances to enhance its product offerings and optimize its distribution channels, further contributing to its revenue.

Axas Holdings Co., Ltd. Financial Statement Overview

Summary
Axas Holdings Co., Ltd. shows moderate revenue growth but struggles with profitability and high leverage. The balance sheet reflects significant debt, posing potential risks. Cash flows are relatively strong, supporting operations despite decreasing free cash flow. Overall, the company exhibits moderate financial health with areas needing improvement, particularly in profitability and leverage management.
Income Statement
65
Positive
The company experienced a modest revenue growth rate of 5.92% from 2023 to 2024. However, margins are concerning, with a low gross profit margin of 25.73% and a net profit margin of 0.27% for 2024. The EBIT margin is a weak 0.12%, though EBITDA margin improved slightly to 4.74%. Overall, profitability is limited, and margins have been under pressure.
Balance Sheet
55
Neutral
The company's debt-to-equity ratio is high at 6.46, indicating substantial leverage. The return on equity (ROE) is low at 1.55%, suggesting limited efficiency in using equity capital. The equity ratio is weak at 12.20%, pointing to heavy reliance on debt financing. These metrics suggest a potentially risky financial structure with limited equity buffer.
Cash Flow
70
Positive
The company's free cash flow decreased by 55.63% from 2023 to 2024. The operating cash flow to net income ratio is strong at 23.89, indicating good cash conversion. Free cash flow to net income ratio stands at 14.07, reflecting sufficient cash flow generation relative to net income despite the decline.
BreakdownTTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income Statement
Total Revenue11.63B11.72B11.06B11.33B11.81B12.49B
Gross Profit3.01B3.01B3.11B3.18B3.21B3.38B
EBITDA498.99M555.76M441.29M722.02M605.05M654.18M
Net Income37.02M31.37M1.03M258.14M205.47M497.25M
Balance Sheet
Total Assets17.59B16.61B17.59B18.91B18.52B17.24B
Cash, Cash Equivalents and Short-Term Investments598.00M1.34B797.92M2.38B4.06B3.27B
Total Debt13.92B13.10B12.79B15.25B14.93B13.75B
Total Liabilities15.68B14.58B15.52B16.74B16.50B15.37B
Stockholders Equity1.92B2.03B2.08B2.18B2.02B1.88B
Cash Flow
Free Cash Flow0.00441.32M994.83M-1.89B-644.17M-1.91B
Operating Cash Flow0.00749.53M1.27B-400.87M158.06M859.11M
Investing Cash Flow0.00-348.90M-153.62M-1.48B-439.00M-2.78B
Financing Cash Flow0.00143.03M-2.70B205.04M1.07B4.57B

Axas Holdings Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price137.00
Price Trends
50DMA
128.28
Positive
100DMA
124.41
Positive
200DMA
122.42
Positive
Market Momentum
MACD
2.12
Negative
RSI
64.62
Neutral
STOCH
61.85
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3536, the sentiment is Positive. The current price of 137 is above the 20-day moving average (MA) of 131.55, above the 50-day MA of 128.28, and above the 200-day MA of 122.42, indicating a bullish trend. The MACD of 2.12 indicates Negative momentum. The RSI at 64.62 is Neutral, neither overbought nor oversold. The STOCH value of 61.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3536.

Axas Holdings Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
¥196.08B21.318.29%2.30%4.93%0.78%
64
Neutral
¥6.29B154.01
1.53%-7.66%
63
Neutral
¥1.70B
7.97%-117.52%
61
Neutral
¥6.22B10.79
2.43%-2.13%
60
Neutral
¥4.15B36.65
1.46%3.75%
60
Neutral
¥2.39B19.85
1.75%2.29%-70.23%
45
Neutral
¥4.86B35.69
1.76%0.10%-239.09%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3536
Axas Holdings Co., Ltd.
135.00
-2.98
-2.16%
JP:4918
Ivy Cosmetics Corporation
326.00
-41.00
-11.17%
JP:4920
Nippon Shikizai, Inc.
1,065.00
-657.34
-38.17%
JP:4925
HABA Laboratories, Inc.
1,660.00
-295.89
-15.13%
JP:4926
C'BON COSMETICS Co., Ltd.
1,136.00
-238.68
-17.36%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
792.00
-75.29
-8.68%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 16, 2025